See All Slides - tctmd.com

Slides

Presentation TCT 2012

Design and Rationale of COAPT

Presenter: Michael Mack

October 24, 2012

Presentation TCT 2012

Micardia Update: Surgical and Percutaneous Device Progress

Presenter: Maurice Buchbinder

October 24, 2012

Presentation TCT 2012

ISAR-LEFT MAIN 2: A Prospective, Randomized Trial of Everolimus-Eluting vs. Zotarolimus-Eluting Stents in Patients with Unprotected Left Main Disease

Presenter: Julinda Mehilli

October 24, 2012

Presentation TCT 2012

How Clever of Me! (My Most Innovative Solution)

Presenter: Sundeep Mishra

October 24, 2012

Presentation TCT 2012

ATLAS ACS-2 TIMI 51: Stent thrombosis in Patients with Acute Coronary Syndromes treated with Rivaroxaban

Presenter: C. Michael Gibson

October 24, 2012

Presentation TCT 2012

Anticoagulation Choices for Atrial Fibrillation: Which Drug for Which Patient?

Presenter: Michael Ezekowitz

October 24, 2012

Presentation TCT 2012

Patient Selection for the MitraClip: Clinical vs. Anatomic Considerations, and Diagnosis of "Severe" MR

Presenter: Robert Siegel

October 24, 2012

Presentation TCT 2012

The Deep Vein Thrombosis Problem: How Strong Is the CAVENT Study Evidence?

Presenter: Anthony Comerota

October 24, 2012

Presentation TCT 2012

Case 2

Presenter: Marian Branny

October 24, 2012

Presentation TCT 2012

Clinical Outcomes After the MitraClip: Risks vs. Benefits (in FMR vs. DMR)

Presenter: Howard Herrmann

October 24, 2012

Advertisement

Slides

Design and Rationale of COAPT

Micardia Update: Surgical and Percutaneous Device Progress

ISAR-LEFT MAIN 2: A Prospective, Randomized Trial of Everolimus-Eluting vs. Zotarolimus-Eluting Stents in Patients with Unprotected Left Main Disease

How Clever of Me! (My Most Innovative Solution)

ATLAS ACS-2 TIMI 51: Stent thrombosis in Patients with Acute Coronary Syndromes treated with Rivaroxaban

Anticoagulation Choices for Atrial Fibrillation: Which Drug for Which Patient?

Patient Selection for the MitraClip: Clinical vs. Anatomic Considerations, and Diagnosis of "Severe" MR

The Deep Vein Thrombosis Problem: How Strong Is the CAVENT Study Evidence?

Case 2

Clinical Outcomes After the MitraClip: Risks vs. Benefits (in FMR vs. DMR)

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content